Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-01

Venkata Suryanarayana Murthy Bhavaraju

Role not yet determined Is this you? Add your title

1 h-index 1 pubs 13 cited

  • COVID-19
  • SARS-CoV-2
  • CRISPR-Cas Systems
  • Gene Editing
  • COVID-19 Testing
  • COVID-19 Drug Treatment
  • Humans

Biography and Research Information

OverviewAI-generated summary

Venkata Suryanarayana Murthy Bhavaraju's research focuses on developing and advancing CRISPR-based technologies for applications in diagnostics and therapeutics, particularly for COVID-19. His work also extends to investigating the etiology and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Bhavaraju has contributed to publications exploring these areas, including a 2024 paper on CRISPR solutions for COVID-19 and a 2025 publication on ADHD treatment directions. His scholarly metrics include an h-index of 1 with one publication and 13 citations. Key collaborators include Shilpi Agrawal, Shivakumar Sonnaila, and Roaa Hadi, all from the University of Arkansas at Fayetteville, with whom he has co-authored multiple publications.

Metrics

  • h-index: 1
  • Publications: 1
  • Citations: 13

Selected Publications

  • Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment (2025)
    NeuroSci 10 citations DOI OpenAlex
  • Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics (2024)
    Cells 13 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

5 Collaborators 5 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics